Dual users had the highest prevalence of respiratory symptoms

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for July 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Learning to …

Full-nut dose lowered HbA1c, estimated cholesterol levels in LDL particles with diameter <255 ångströms

First systemic treatment for patients who experience tumor-related symptoms such as hypertension

Herbal, chiropractic, massage, acupuncture, yoga most commonly used individual therapies

Use of acute care service five-fold higher after interruption in insurance versus before interruption

Results suggest the need for screening, surveillance in survivors

Increased risks for those with diabetes and asymptomatic left ventricular systolic dysfunction

Adherence to regimen needed to cut subsequent fracture risk

Small changes in health behaviors seen for partners of those newly diagnosed with diabetes